Interv Akut Kardiol. 2022;21(1):41-44 | DOI: 10.36290/kar.2022.002

Triple combination, double meaning

Vojtěch Novotný
Kardiologické centrum Agel, a. s., Pardubice

The case report presents two views on the concept of "triple combination" in treating a particular patient with coronary artery disease. The first, somewhat untraditional meaning of the two-word expression is used to describe an unusual case of three chronic total occlusions (CTO) in three different coronary territories clinically manifested by heart failure in the setting of ischaemic cardiomyopathy. All the occlusions were gradually recanalized using CTO PCI techniques with a good angiographic and clinical effect. There was a marked improvement in the original systolic left ventricular dysfunction. The individual procedures are illustrated by images and accompanied by general information on CTO PCI. A second meaning of the words "triple combination" - in a more traditional pharmacotherapeutic sense - represents a fixed combination of three antihypertensive and lipid-lowering drugs which were used in the same patient to optimize the secondary preventive therapeutic regimen.

Keywords: fixed combination, chronic total occlusion, CTO, PCI, secondary prevention, case report.

Received: January 18, 2022; Revised: January 18, 2022; Accepted: January 18, 2022; Prepublished online: January 18, 2022; Published: March 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novotný V. Triple combination, double meaning. Interv Akut Kardiol. 2022;21(1):41-44. doi: 10.36290/kar.2022.002.
Download citation

References

  1. Mates M, Kala P, Paleček T, Sovová E, Skalická H. Doporučené postupy ESC pro diagnózu a léčbu chronických koronárních syndromů, 2019. Souhrn dokumentu vypracovaný Českou kardiologickou společností. Cor Vasa. 2020;62(2):199-233. Go to original source...
  2. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020;41:407-477. Go to original source... Go to PubMed...
  3. Ybarra LF, Rinfret S, Brilakis ES, et al. Chronic Total Occlusion Academic Research Consortium. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO­‑ARC Consensus Recommendations. Circulation. 2021;143(5):479-500. Go to original source... Go to PubMed...
  4. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59(11):991-997. Go to original source... Go to PubMed...
  5. Brilakis ES, Mashayekhi K, Tsuchikane E, et al. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention. Circulation. 2019;140(5):420-433. Go to original source... Go to PubMed...
  6. Novotný V, Varvařovský I, Lazarák T, et al. Zkušenosti s rekanalizacemi obtížnějších chronických totálních uzávěrů (CTO). Interv Akut Kardiol. 2019;18(1):12-17. Go to original source...
  7. Yoshihiro M, Mitsuru A, Takeshi M, et al. Predicting Successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: The J­‑CTO (Multicenter CTO Registry in Japan) Score as a Difficulty Grading and Time Assessment Tool. JACC Cardiovasc Interv. 2011;4(2):213-221. Go to original source... Go to PubMed...
  8. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed­‑dose combinations of antihypertensive agents: a meta­‑analysis. Hypertension. 2010;55(2):399-407. Go to original source... Go to PubMed...
  9. Visseren FLJ, Mach F, Smulders YM, et al.; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.